Sonoma Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1999-01-01
- Employees
- 171
- Market Cap
- $4.4M
- Website
- http://www.sonomapharma.com
- Introduction
Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.
Sonoma Pharma Secures FDA Clearance for Enhanced Wound Care Hydrogel Technology
Sonoma Pharmaceuticals received new FDA 510(k) clearance for Microcyn-based hydrogel with improved biocompatibility and 24-month shelf life for 50mL bottles, usable for professional wound care and OTC minor skin irritations.
Sonoma Pharmaceuticals and EMC Pharma Roll Out Collaboration to Co-Market Expanded Eye Care Product Line
Sonoma Pharmaceuticals and EMC Pharma have entered a co-marketing agreement to launch an expanded prescription and OTC eye care product line. The line, featuring Ocucyn Eyelid and Eyelash Cleanser with improved packaging, will debut at the American Academy of Ophthalmology's annual meeting in October 2024. The agreement builds on a 2021 distribution deal, granting EMC Pharma rights to sell OTC Ocucyn and Sonoma rights to sell prescription Acuicyn. Both products use hypochlorous acid-based Microcyn technology for gentle eye cleansing.
© Copyright 2024. All Rights Reserved by MedPath